Summit Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.7M | 76k | 21.90 |
| 2024-06-30 | $496k | 64k | 7.80 |
| 2024-03-31 | $2.3M | 559k | 4.16 |
| 2023-12-31 | $76k | 29k | 2.62 |
| 2023-09-30 | $17k | 9.1k | 1.83 |
| 2023-03-31 | $105k | 60k | 1.75 |
| 2022-12-31 | $235k | 55k | 4.25 |
| 2022-09-30 | $3.0k | 2.5k | 1.18 |
| 2021-12-31 | $28k | 11k | 2.67 |
| 2021-03-31 | $90k | 15k | 5.87 |
| 2020-12-31 | $13k | 2.7k | 4.86 |
| 2020-09-30 | $1.0k | 200 | 5.00 |